These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 33164088)
1. COVID-19 and rheumatic musculoskeletal disease patients: infection rates, attitudes and medication adherence in an Irish population. Murray K; Quinn S; Turk M; O'Rourke A; Molloy E; O'Neill L; Mongey AB; Fearon U; Veale DJ Rheumatology (Oxford); 2021 Feb; 60(2):902-906. PubMed ID: 33164088 [TBL] [Abstract][Full Text] [Related]
2. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Gianfrancesco M; Hyrich KL; Al-Adely S; Carmona L; Danila MI; Gossec L; Izadi Z; Jacobsohn L; Katz P; Lawson-Tovey S; Mateus EF; Rush S; Schmajuk G; Simard J; Strangfeld A; Trupin L; Wysham KD; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Yazdany J; Machado PM; Robinson PC; Ann Rheum Dis; 2020 Jul; 79(7):859-866. PubMed ID: 32471903 [TBL] [Abstract][Full Text] [Related]
3. What is the true incidence of COVID-19 in patients with rheumatic diseases? Favalli EG; Ingegnoli F; Cimaz R; Caporali R Ann Rheum Dis; 2021 Feb; 80(2):e18. PubMed ID: 32321723 [No Abstract] [Full Text] [Related]
4. Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry. Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Ostergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Agerbo J; Ziegler C; Hetland M RMD Open; 2021 Jan; 7(1):. PubMed ID: 33402443 [TBL] [Abstract][Full Text] [Related]
5. Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies. Sanchez-Piedra C; Diaz-Torne C; Manero J; Pego-Reigosa JM; Rúa-Figueroa Í; Gonzalez-Gay MA; Gomez-Reino J; Alvaro-Gracia JM; Ann Rheum Dis; 2020 Jul; 79(7):988-990. PubMed ID: 32503857 [No Abstract] [Full Text] [Related]
6. Changes in Disease-Modifying Antirheumatic Drug Treatment for Patients With Rheumatoid Arthritis in the US During the COVID-19 Pandemic: A Three-Month Observational Study. Michaud K; Pedro S; Wipfler K; Agarwal E; Katz P Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1322-1331. PubMed ID: 33787086 [TBL] [Abstract][Full Text] [Related]
7. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases. Hasseli R; Mueller-Ladner U; Hoyer BF; Krause A; Lorenz HM; Pfeil A; Richter J; Schäfer M; Schmeiser T; Strangfeld A; Schulze-Koops H; Voll RE; Specker C; Regierer AC RMD Open; 2021 Jan; 7(1):. PubMed ID: 33479021 [TBL] [Abstract][Full Text] [Related]
8. Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil. Pileggi GS; Ferreira GA; Reis APMG; Reis-Neto ET; Abreu MM; Albuquerque CP; Araújo NC; Bacchiega AB; Bianchi DV; Bica B; Bonfa ED; Borba EF; Brito DCSE; Duarte ÂLBP; Santo RCE; Fernandes PR; Guimarães MP; Gomes KWP; Kakehasi AM; Klumb EM; Lanna CCD; Marques CDL; Monticielo OA; Mota LMH; Munhoz GA; Paiva ES; Pereira HLA; Provenza JR; Ribeiro SLE; Junior LFR; Sampaio CSJC; Sampaio VS; Sato EI; Skare T; de Souza VA; Valim V; Lacerda MVG; Xavier RM; Pinheiro MM Adv Rheumatol; 2021 Oct; 61(1):60. PubMed ID: 34620246 [TBL] [Abstract][Full Text] [Related]
9. Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic. Tam LS; Tanaka Y; Handa R; Li Z; Lorenzo JP; Louthrenoo W; Hill C; Pile K; Robinson PC; Dans LF; Hsu LY; Lee SM; Cho J; Hasan ATMT; Salim B; Samreen S; Shaharir SS; Wong P; Chau J; Danda D; Haq SA Int J Rheum Dis; 2021 Jun; 24(6):733-745. PubMed ID: 33945214 [TBL] [Abstract][Full Text] [Related]
10. Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe? Santos CS; Férnandez XC; Moriano Morales C; Álvarez ED; Álvarez Castro C; López Robles A; Pérez Sandoval T RMD Open; 2021 Jan; 7(1):. PubMed ID: 33455920 [TBL] [Abstract][Full Text] [Related]
11. Influence of the COVID-19 Pandemic on Medical Management and on Healthcare Delivery of Immune-Mediated Rheumatic and Musculoskeletal Diseases during the First Pandemic Period February to July 2020: A Systematic Review. Schlegel M; Bachmann S Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674242 [TBL] [Abstract][Full Text] [Related]
12. COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence. Costantino F; Bahier L; Tarancón LC; Leboime A; Vidal F; Bessalah L; Breban M; D'Agostino MA Joint Bone Spine; 2021 Jan; 88(1):105095. PubMed ID: 33152484 [TBL] [Abstract][Full Text] [Related]
13. Modifications in Systemic Rheumatic Disease Medications: Patients' Perspectives During the Height of the COVID-19 Pandemic in New York City. Mancuso CA; Duculan R; Jannat-Khah D; Barbhaiya M; Bass AR; Mandl LA; Mehta B Arthritis Care Res (Hoboken); 2021 Jun; 73(6):909-917. PubMed ID: 33085850 [TBL] [Abstract][Full Text] [Related]
14. Qualitative assessment of medication adherence in patients with rheumatic diseases on biologic therapy. Raghunath S; Hijjawi R; Hoon E; Shanahan EM; Goldblatt F Clin Rheumatol; 2019 Oct; 38(10):2699-2707. PubMed ID: 31172365 [TBL] [Abstract][Full Text] [Related]
15. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs. Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260 [TBL] [Abstract][Full Text] [Related]
16. Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database. Sfikakis PP; Bournia VK; Sidiropoulos P; Boumpas DT; Drosos AA; Kitas GD; Konstantonis G; Liossis SN; Manoussakis MN; Sakkas L; Tektonidou M; Tzioufas AG; Vlachoyiannopoulos PG; Kani C; Paterakis P; Litsa P; Vassilopoulos D Clin Exp Rheumatol; 2017; 35(4):579-585. PubMed ID: 28281458 [TBL] [Abstract][Full Text] [Related]